Policymakers are leaning into prescription drug pricing reform with the consumer in mind, aiming to lower costs and provide more payment options and transparency. Rachel Stauffer and Jeffrey Davis join the Breakroom to explore these recent efforts in both the legislative and regulatory arenas.
Read more about this topic in our Regs & Eggs blog.
